Liraglutide/insulin degludec
| Combination of | |
|---|---|
| Liraglutide | glucagon-like peptide-1 receptor agonist |
| Insulin degludec | insulin analog |
| Clinical data | |
| Trade names | Xultophy |
| Legal status | |
| Legal status |
|
Liraglutide/insulin degludec (trade name Xultophy) is a combination drug consisting of:
- Liraglutide, a long-acting glucagon-like peptide-1 receptor agonist
- Insulin degludec, an ultralong-acting basal insulin analogue
Reference
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.